Results 1 to 10 of about 106,528 (297)

A paradigm shift in psoriasis treatment: deucravacitinib's significance. [PDF]

Ann Med Surg (Lond), 2023
Ishtiaque GMA, Supti FA, Amin R, Emran TB.   +3 more
europepmc   +2 more sources

Nano-based formulations of thymoquinone are new approaches for psoriasis treatment: a literature review. [PDF]

Front Immunol
Modarresi Chahardehi A, Ojaghi HR, Motedayyen H, Arefnezhad R.   +3 more
europepmc   +3 more sources

Molecular and functional changes in neutrophilic granulocytes induced by nicotine: a systematic review and critical evaluation

Frontiers in Immunology, 2023
BackgroundOver 1.1 billion people smoke worldwide. The alkaloid nicotine is a prominent and addictive component of tobacco. In addition to tumors and cardiovascular disorders, tobacco consumption is associated with a variety of chronic-inflammatory ...
Theresa-Charlotte Brembach, Theresa-Charlotte Brembach, Robert Sabat, Katrin Witte, Tanja Schwerdtle, Tanja Schwerdtle, Kerstin Wolk   +6 more
doaj   +1 more source

Features Associated With Quality of Life Impairment in Hidradenitis Suppurativa Patients

Frontiers in Medicine, 2021
Background: Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with an adverse impact on patients' quality of life (QoL).Objectives: To quantify QoL impairment in patients in Germany suffering from HS and to identify the parameters ...
Sylke Schneider-Burrus, Sylke Schneider-Burrus, Athanasia Tsaousi, Sebastian Barbus, Johannes Huss-Marp, Katrin Witte, Katrin Witte, Katrin Witte, Kerstin Wolk, Kerstin Wolk, Kerstin Wolk, Kerstin Wolk, Björn Fritz, Robert Sabat, Robert Sabat   +14 more
doaj   +1 more source

Brodalumab for the treatment of plaque psoriasis in a real-life setting: a 3 years multicenter retrospective study—IL PSO (Italian landscape psoriasis)

Frontiers in Medicine, 2023
IntroductionBrodalumab is a monoclonal antibody that targets the subunit A of the interleukin-17A receptor (IL17RA), inhibiting the signaling of various isoforms of the IL-17 family.
Luigi Gargiulo, Luigi Gargiulo, Luciano Ibba, Luciano Ibba, Piergiorgio Malagoli, Fabrizio Amoruso, Giuseppe Argenziano, Anna Balato, Federico Bardazzi, Martina Burlando, Carlo Giovanni Carrera, Giovanni Damiani, Paolo Dapavo, Valentina Dini, Gabriella Fabbrocini, Chiara Franchi, Francesca Maria Gaiani, Giampiero Girolomoni, Claudio Guarneri, Claudia Lasagni, Francesco Loconsole, Angelo Valerio Marzano, Angelo Valerio Marzano, Matteo Megna, Francesca Sampogna, Massimo Travaglini, Antonio Costanzo, Antonio Costanzo, Alessandra Narcisi   +28 more
doaj   +1 more source

Adjunctive Use of Calcipotriene/Betamethasone Dipropionate Foam in a Real-World Setting Curtails the Cost of Biologics Without Reducing Efficacy in Psoriasis

Dermatology and Therapy, 2020
Introduction Although the efficacy of monotherapy with biologics for psoriasis is well established, many patients fail to achieve complete plaque clearance from their initial biologic treatment alone.
Jerry Bagel, Elise Nelson, James Zapata, Alexa Hetzel   +3 more
doaj   +1 more source

Novel Coronavirus Disease (COVID-19) and Biologic Therapy in Psoriasis: Infection Risk and Patient Counseling in Uncertain Times

Dermatology and Therapy, 2020
With the emergence of the novel coronavirus disease (COVID-19) viral pandemic, there is uncertainty whether biologic agents for psoriasis may place patients at a higher risk for infection or more severe disease course.
Nicholas D. Brownstone, Quinn G. Thibodeaux, Vidhatha D. Reddy, Bridget A. Myers, Stephanie Y. Chan, Tina Bhutani, Wilson Liao   +6 more
doaj   +1 more source

Novel Coronavirus Disease (COVID-19) and Biologic Therapy for Psoriasis: Successful Recovery in Two Patients After Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Dermatology and Therapy, 2020
The outbreak of the novel coronavirus known as SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) causing COVID-19 was first reported in late December 2019.
Nicholas D. Brownstone, Quinn G. Thibodeaux, Vidhatha D. Reddy, Bridget A. Myers, Stephanie Y. Chan, Tina Bhutani, Wilson Liao   +6 more
doaj   +1 more source

Sex-disaggregated population analysis in patients with hidradenitis suppurativa

Frontiers in Medicine, 2022
BackgroundHidradenitis suppurativa (HS) is a common chronic inflammatory skin disease, which affects both sexes.ObjectivesIdentification of sex-specific risk factors, comorbidity, clinical manifestations, and treatments in HS patients.MethodsA non ...
Robert Sabat, Robert Sabat, Athanasia Tsaousi, Kamran Ghoreschi, Kerstin Wolk, Kerstin Wolk, Sylke Schneider-Burrus, Sylke Schneider-Burrus   +7 more
doaj   +1 more source

Effectiveness and safety of bimekizumab for the treatment of plaque psoriasis: a real-life multicenter study—IL PSO (Italian landscape psoriasis)

Frontiers in Medicine, 2023
IntroductionBimekizumab is a monoclonal antibody that targets Interleukin-17 A and F, approved for the treatment of moderate-to-severe plaque psoriasis.
Luigi Gargiulo, Luigi Gargiulo, Alessandra Narcisi, Luciano Ibba, Luciano Ibba, Anna Balato, Luca Bianchi, Pina Brianti, Dario Buononato, Martina Burlando, Giacomo Caldarola, Giacomo Caldarola, Anna Campanati, Elena Campione, Carlo G. Carrera, Andrea Carugno, Andrea Carugno, Antonio Cristaudo, Francesco Cusano, Paolo Dapavo, Annunziata Dattola, Clara De Simone, Clara De Simone, Francesca M. Gaiani, Paolo Gisondi, Alessandro Giunta, Francesco Loconsole, Vincenzo Maione, Edoardo Mortato, Angelo V. Marzano, Angelo V. Marzano, Martina Maurelli, Matteo Megna, Santo R. Mercuri, Annamaria Offidani, Diego Orsini, Aurora Parodi, Giovanni Pellacani, Luca Potestio, Pietro Quaglino, Antonio G. Richetta, Francesca Romano, Paolo Sena, Marina Venturini, Piergiorgio Malagoli, Antonio Costanzo, Antonio Costanzo   +46 more
doaj   +1 more source